A competing risk model to estimate the hospitalisation story of a cohort of diabetic patients. The additive regression model.

Similar documents
Lucia Cea Soriano 1, Saga Johansson 2, Bergur Stefansson 2 and Luis A García Rodríguez 1*

ESM1 for Glucose, blood pressure and cholesterol levels and their relationships to clinical outcomes in type 2 diabetes: a retrospective cohort study

Discontinuation and restarting in patients on statin treatment: prospective open cohort study using a primary care database

Sleep Apnea: Vascular and Metabolic Complications

Race Original cohort Clean cohort HR 95%CI P HR 95%CI P. <8.5 White Black

Title: Hospitalization rates and cost in severe or complicated obesity: An Italian cohort study.

Nephropathy in Type 1 Diabetes: Can One Identity the Patients at Risk?

Risk of mortality and adverse cardiovascular outcomes in type 2 diabetes: a comparison of patients treated with sulfonylureas and metformin

NCAP NATIONAL CARDIAC AUDIT PROGR AMME NATIONAL HEART FAILURE AUDIT 2016/17 SUMMARY REPORT

The effect of surgeon volume on procedure selection in non-small cell lung cancer surgeries. Dr. Christian Finley MD MPH FRCSC McMaster University

Supplementary Online Content

Quality of prescribing in chronic kidney disease and type 2 diabetes Smits, Kirsten Petronella Juliana

SUPPLEMENTARY DATA. Supplementary Figure S1. Cohort definition flow chart.

Preoperative tests (update)

had non-continuous enrolment in Medicare Part A or Part B during the year following initial admission;

Long-Term Use of Long-Acting Insulin Analogs and Breast Cancer Incidence in Women with Type 2 Diabetes.

EACTS Adult Cardiac Database

JAMA, January 11, 2012 Vol 307, No. 2

DECLARATION OF CONFLICT OF INTEREST

Measure #164 (NQF 0129): Coronary Artery Bypass Graft (CABG): Prolonged Intubation National Quality Strategy Domain: Effective Clinical Care

Monitoring the prevalence of diabetes and the quality of care using electronic health data

Chronic Kidney Disease (CKD) in the Darling Downs- a Registry report

Echocardiographic Correlates of Pulmonary Artery Systolic Pressure

Epidemiologic Measure of Association

Finland and Sweden and UK GP-HOSP datasets

Surgical Outcomes: A synopsis & commentary on the Cardiac Care Quality Indicators Report. May 2018

Redgrave JN, Coutts SB, Schulz UG et al. Systematic review of associations between the presence of acute ischemic lesions on

Normal Fasting Plasma Glucose and Risk of Type 2 Diabetes Diagnosis

PROTEZIONE DAL DANNO RENALE NEL DIABETE TIPO 2: RUOLO DEI NUOVI FARMACI. Massimo Boemi UOC Malattie Metaboliche e Diabetologia IRCCS INRCA Ancona

Socioeconomic status and the 25x25 risk factors as determinants of premature mortality: a multicohort study of 1.7 million men and women

Is laparoscopic sleeve gastrectomy safer than laparoscopic gastric bypass?

AHA Clinical Science Special Report: November 10, 2015

FIRST RENAL REPLACEMENT

Impaired Chronotropic Response to Exercise Stress Testing in Patients with Diabetes Predicts Future Cardiovascular Events

Preoperative tests (update)

Supplementary Online Content

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Vanessa L.Z. Gordon-Dseagu. UCL Department of Epidemiology of Public Health 1-19 Torrington Place London WC1E 6BT. PhD

Secondary analyses of HSE data and linked health outcomes - an overview of work in progress. UCL (University College London)

Supplementary appendix

Use of Anti-Psychotic Agents in Irish Long Term Care Residents with Dementia

Small dense low-density lipoprotein is a risk for coronary artery disease in an urban Japanese cohort: The Suita study

A Comparison of Analytic Models for the Costs of the Hospitalized Diabetic Patients

Magnetic resonance imaging, image analysis:visual scoring of white matter

Ulster, Ireland. Submitted: 21 June 2009; Revised: 24 January 2010; Published: 13 September 2010 Petrazzuoli F, Soler JK, Buono N, Dobbs F

GALECTIN-3 PREDICTS LONG TERM CARDIOVASCULAR DEATH IN HIGH-RISK CORONARY ARTERY DISEASE PATIENTS

Aldo P. Maggioni, Kees Van Gool, Nelly Biondi, Renato Urso, Niek Klazinga, Roberto Ferrari, Nikolaos Maniadakis and Luigi Tavazzi.

Normal Parameters: Age 65 years and older BMI 23 and < 30 kg/m 2 Age years BMI 18.5 and < 25 kg/m 2

Rayzel Shulman MD, PhD CAHSPR May 10, 2016

FEV1 predicts length of stay and in-hospital mortality in patients undergoing cardiac surgery

Declaration of Conflict of Interest. No potential conflict of interest to disclose with regard to the topics of this presentations.

Prof. Samir Morcos Rafla Alexandria Univ. Cardiology Dept.

ASCEND A randomized trial of omega-3 fatty acids (fish oil) versus placebo for primary cardiovascular prevention in 15,480 patients with diabetes

Supplementary Online Content

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARDS FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

Do Elderly Men Have Increased Mortality Following Hip Fracture?

Clinical Staging for Obesity. Raj Padwal Clinical Pharmacology and General Internal Medicine University of Alberta

T2 Diabetes in Sep-16. Stephen Leow Disclosures. Why do we treat diabetes? Agenda. Targets

Combined oral contraceptives and risk of venous thromboembolism: nested case control studies using the QResearch and the CPRD databases

Microvascular Disease in Type 1 Diabetes

Supplemental Table 1. Standardized Serum Creatinine Measurements. Supplemental Table 3. Sensitivity Analyses with Additional Mortality Outcomes.

Risk of renal side effects with ADT. E. David Crawford University of Colorado, Aurora, CO, USA

Expanded Criteria Recipients: Are there any Limits

SUPPLEMENTAL MATERIALS

Appendix: Supplementary tables [posted as supplied by author]

COMPLICATIONS OF PRE-GESTATIONAL AND GESTATIONAL DIABETES IN SAUDI WOMEN: ANALYSIS FROM RIYADH MOTHER AND BABY COHORT STUDY (RAHMA)

GSK Medicine: Study Number: Title: Rationale: Phase: Study Period: Study Design: Centres: Indication: Treatment: Objectives:

. 10. Hydration and nutrition 10.2 Assessment of swallowing function

Real World Evidence: From Efficacy to Effectiveness

Glucose and CV disease

University College Hospital. Blood glucose and HbA 1 c targets

SCIENTIFIC DOSSIER ON: Hydration and Outcome in Older Patients admitted to hospital ( The HOOP prospective cohort study)

Ryan Salter, Michael Bailey, Rinaldo Bellomo, Glenn Eastwood, Niklas Nielsen, David Pilcher, Alistair Nichol, Manoj Saxena, Yahya Shehabi, Paul Young

Supplemental Table 1. Study design and participant characteristics.

Surveillance report Published: 6 April 2016 nice.org.uk. NICE All rights reserved.

EPO-144 Patients with Morbid Obesity and Congestive Heart Failure Have Longer Operative Time and Room Time in Total Hip Arthroplasty

Obesity & Metabolic (Diabetes) Surgery

Moving to an A1C-Based Screening & Diagnosis of Diabetes. By Prof.M.Assy Diabetes&Endocrinology unit

Mémoire de Maîtrise en médecine No 778. Etudiant Tania Soccorsi. Tuteur Dr Jean-Pierre Revelly Service de Médecine Intensive Adulte, CHUV

Why Do We Care About Prediabetes?

NQF-ENDORSED VOLUNTARY CONSENSUS STANDARD FOR HOSPITAL CARE. Measure Information Form Collected For: CMS Outcome Measures (Claims Based)

What is the risk of venous thromboembolism (VTE) in patients treated by an Outpatient Parenteral Antimicrobial Therapy (OPAT) Service?

Optimizing Patient Outcomes Following Orthopedic Surgery: The Role of Albumin and the Case For Fast- Track

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

Supplementary Appendix

Townsville Broadband Diabetes Telehealth Trial EVALUATION REPORT. May 2015

Setting The setting was the Walter Reed Army Medical Center. The economic study was carried out in the USA.

Outcomes: Initially, our primary definitions of pneumonia was severe pneumonia, where the subject was hospitalized

Cardiovascular Diabetology. Open Access ORIGINAL INVESTIGATION. C. R. L. Cardoso 1, N. C. Leite 1, C. B. M. Moram 2 and G. F.

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:


Case study: Individual with inadequate glycaemic control due to poor adherence to medication

Clinical Phenotypes and In-hospital Management and Prognosis in Diabetic versus Non-diabetic Patients with Acute Heart Failure in ALARM-HF Registry

Heart Failure and COPD: Common Partners, Common Problems. Nat Hawkins Liverpool Heart and Chest Hospital

MEDICATIONS PRESCRIPTION AT HOSPITAL DISCHARGE IN PATIENTS WITH VALIDATED DIAGNOSIS OF DEMENTIA. Federica Edith Pisa University Hospital Udine

MEDCODE READCODE READTERM

Dr Tahseen A. Chowdhury Royal London Hospital. New Guidelines in Diabetes: NICE or Nasty?

Research Article Diabetic Microangiopathy Is an Independent Predictor of Incident Diabetic Foot Ulcer

Table S1. Read and ICD 10 diagnosis codes for polymyalgia rheumatica and giant cell arteritis

Transcription:

A competing risk model to estimate the hospitalisation story of a cohort of diabetic patients. The additive regression model. PHD Thesis Project Rosalba Rosato Dept.of Statistics, University of Florence, Italy Prof. Annibale Biggeri Prof. Dario Gregori 27/09/2002 1

The aim of the study is to analyse the hospitalisation story of a cohort of diabetic patients. Each patient during the period could have one or more hospital admissions. The admissions are classified according to the main cause in: 1. Hospital admission related to diabetes 2. Hospital admission for other causes Mortality patients has been also evaluated. Our analysis include two different outcomes: - one absorbing state as death - and hospitalisation classified in: - Admission related to diabetes - Admission for other causes 27/09/2002 2

Database A cohort of 3892 of type 2 diabetic patients, attending the Diabetic Clinic of the Major Hospital of Turin, Italy during 1995 and alive at 1 st January 1996 was identified. For each patient we have some information (relative to the year 1995) selected as potential risk factors for hospitalisation: 1. Demographic data (age, sex area of residence) and 2. Clinical data (weight, duration of disease, glycated haemoglobin, type of anti-diabetic treatment and presence of other comorbidities). A mortality follow-up of the cohort was carried out up to 30 th June 2000. Hospital admissions were recorded for all patients from 1 st January 1996 to 30 th June 2000. 27/09/2002 3

Possible transition 1 People start with 0 hospitalisation Diab. Admis Other Admis. DEATH Diab. Admis. Other admis. Diab. Admis. Other admis Diab. Admis Other admis Diab. Admis Other admis Diab. Admis Other admis Diab. Admis Other admis 1/1/1996 27/09/2002 4

Possible transition 2 1 st event 2 nd event 3 rd event. Diab. A Diab. A Diab. A Other A Other A Other A People start with 0 hospitalisation 1/1/1996 DEATH DEATH DEATH 27/09/2002 5

During the follow-up (Jannuary1996-June June 2000) we have: *** 1770 patients with 0 hospital admission *** 2122 patients have had 1 or more admissions (total 5465 hospital admissions) *** 599 patients died type admission frequencies percentage 0 NO 1770 24,5 1 DIABETES 1988 27,5 2 OTHER 3477 48,0 27/09/2002 6

EXAMPLE subject 1 has had 3 hospital admission during the period and then is dead ID NH TYPE AD STAT SSMORT START D.IN.H D.OUT.H DDEC T_IN_HOSP STARTTY ENDTY 1 1 1 1 0 01/01/1996 14/11/1997 05/12/1997 21 0 683 1 2 2 1 0 02/01/1996 19/05/1999 21/05/1999 2 0 530 1 3 2 1 0 03/01/1996 07/10/1999 27/10/1999 20 0 139 1 3 2 1 01/12/1999 0 35 EXAMPLE PATIENT 1 638 days 530 days diabetes other 139 days other 35 days 21 2 20 1/1/1996 1/12/1999 Time of observation since last event The outlined line represents time when the patient was in hospital 27/09/2002 7

Frequency distribution variable: number of hospitalisation (NH) Cumulative NH Frequency Percentage frequency percentage ƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒƒ 0 1770 24.46 1770 24.46 1 2122 29.33 3892 53.79 2 1232 17.03 5124 70.82 3 744 10.28 5868 81.11 4 451 6.23 6319 87.34 5 294 4.06 6613 91.40 6 193 2.67 6806 94.07 7 133 1.84 6939 95.91 8 87 1.20 7026 97.11 9 62 0.86 7088 97.97 10 44 0.61 7132 98.58 11 27 0.37 7159 98.95 12 22 0.30 7181 99.25 13 15 0.21 7196 99.46 14 10 0.14 7206 99.60 15 8 0.11 7214 99.71 16 5 0.07 7219 99.78 17 2 0.03 7221 99.81 18 2 0.03 7223 99.83 19 2 0.03 7225 99.86 20 2 0.03 7227 99.89 21 2 0.03 7229 99.92 22 1 0.01 7230 99.93 23 1 0.01 7231 99.94 24 1 0.01 7232 99.96 25 1 0.01 7233 99.97 26 1 0.01 7234 99.99 27 1 0.01 7235 100.00 27/09/2002 8

Characteristics of the patients by number of hospital admissions. N of hospital admissions: 0 1 2 Number of patients (%) 1770 (45.5) 890 (22.9) 1232 (31.6) Number of admissions: mean 0 1 3.71 (2-27) (range) Days of hospital stay: mean 0 10.2 (9102) 15.0 (68482) (total) Age: mean (SD) 62.7 (10.1) 65.3 (10.3) 67.0 (9.8) Male % 52.0 51.5 51.5 BMI kg/m 2 : mean (SD) 28.1 (4.8) 28.2 (4.8) 28.4 (4.7) Diabetes duration in years: mean 10.4 (8.1) 12.0 (8.5) 13.2 (8.9) (SD) HbA 1 c %: mean (SD) 7.76 (1.58) 7.99 (1.61) 8.15 (1.57) Hypertension % 71.0 78.9 79.5 Insulin treatment % 19.7 26.7 35.8 Retinopathy % 26.2 28.5 34.2 Nephropathy % 29.9 37.3 48.2 Coronary artery disease % 8.0 12.9 19.1 Peripheral artery disease % 6.6 11.0 14.1 Co-morbidity % 8.5 11.9 17.8 Cirrhosis % 2.1 2.1 4.6 Cancer % 3.4 5.6 7.9 Chronic obstructive pulmonary 1.1 2.7 3.7 diseases % 27/09/2002 Psychiatric diseases % 2.1 1.9 2.7 9

Risk factors for hospitalization without classification of admissions. sions. Conditional Cox model for repeated events HR* 95 % CI p Age (years) 1.02 1.01 1.02 <0.0001 Sex (males) 1.04 0.98 1.10 0.230 Duration of diabetes (years) 1.00 1.00 1.01 0.090 HbA 1 c % 1.02 1.00 1.04 0.047 BMI 25 (kg/m 2 ) 1.05 0.98 1.14 0.176 BMI 30 (kg/m 2 ) 1.10 1.03 1.17 0.005 Hypertension 0.94 0.87 1.01 0.108 Insulin treatment 1.21 1.13 1.29 <0.0001 Retinopathy 1.04 0.98 1.11 0.226 Nephropathy 1.25 1.18 1.33 <0.0001 Coronary artery disease 1.27 1.18 1.36 <0.0001 Peripheral artery disease 1.22 1.13 1.33 <0.0001 Co-morbidity 1.40 1.30 1.51 <0.0001 Cirrhosis 1.44 1.27 1.64 <0.0001 Cancer 1.41 1.26 1.58 <0.0001 Chronic obstructive pulmonary 1.28 1.13 1.44 <0.0001 diseases Psychiatric diseases 1.25 1.04 1.49 0.014 27/09/2002 10

Comments The additive regression model has been proposed to estimate survival probability in presence of competing risk for modelling each transition as a Markov chain on the basis of subject information and their previous story (Aalen et al. 2001). In order to estimate the probability to have one or more hospital admissions is very important to keep in mind what is happened previously. The hospitalisation story of a patient follow a Markov chain model? When stooped transition Goodness of fit and selection model Other and other. 27/09/2002 11